expect a 20% IGF-1 increase. Use this as an initial guide, not a fixed prescriptionverify with your clinician
The peptide's combined sleep-promoting and analgesic properties may be particularly relevant for pain conditions where sleep disruption exacerbates pain perception in a vicious cycle
Finally, clinical studies in humans represent the highest level of evidence
doi: 10.3389/fendo.2025.1562518 Received 17 January 2025 Accepted 12 August 2025 Published 04 September 2025 Volume 16 - 2025 Edited by Sang Youb Han, Inje University Ilsan Paik Hospital, Republic of Korea Reviewed by Idris Long, University of Science Malaysia (USM), Malaysia Jorge Rico-Fontalvo, Simn Bolvar University, Colombia Updates Copyright 2025 Xu, Miao, Chen and Liao
Access is currently limited to clinical trials and expanded access programs